Unknown

Dataset Information

0

A critical role of epigenetic inactivation of miR-9 in EVI1high pediatric AML.


ABSTRACT: Ectopic Viral Integration site 1 (EVI1) upregulation is implicated in 10-25% of pediatric acute myeloid leukemia (AML) and has an inferior outcome with current chemotherapy regimens. Here we report that EVI1 upregulation is associated with methylation of the miR-9 promoter and correlated with downregulation of miR-9 in human AML cell lines and bone marrow (BM) cells from pediatric patients. Reactivation of miR-9 by hypomethylating agents and forced expression of miR-9 in EVI1high leukemia cell lines and primary leukemia cells results in apoptosis and decreased proliferation of EVI1high leukemia cells. Furthermore, re-expression of miR-9 delays disease progression in EVI1high leukemia-xenograft mice. Our results suggest that EVI1-induced hypermethylation and downregulation of the miR-9 plays an important role in leukemogenesis in EVI-1high pediatric AML, indicating that hypomethylating agents may be a potential therapeutic strategy for EVI1high pediatric AML.

SUBMITTER: Mittal N 

PROVIDER: S-EPMC6391809 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3694976 | BioStudies
2013-01-01 | S-EPMC3764604 | BioStudies
1000-01-01 | S-EPMC4709720 | BioStudies
2013-01-01 | S-EPMC4693300 | BioStudies
1000-01-01 | S-EPMC5406602 | BioStudies
2012-01-01 | S-EPMC3266272 | BioStudies
2020-01-01 | S-EPMC7395283 | BioStudies
2020-01-01 | S-EPMC7493963 | BioStudies
2016-01-01 | S-EPMC5019412 | BioStudies
2020-01-01 | S-EPMC7600968 | BioStudies